Charles Schwab’s Emergent Biosolutions EBS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$7.05M Buy
1,105,184
+521,913
+89% +$3.33M ﹤0.01% 2176
2025
Q1
$2.83M Sell
583,271
-706,959
-55% -$3.44M ﹤0.01% 2506
2024
Q4
$12.3M Sell
1,290,230
-934,497
-42% -$8.93M ﹤0.01% 1920
2024
Q3
$18.6M Sell
2,224,727
-941,519
-30% -$7.86M ﹤0.01% 1731
2024
Q2
$21.6M Sell
3,166,246
-985,073
-24% -$6.72M ﹤0.01% 1629
2024
Q1
$10.5M Buy
4,151,319
+1,277,335
+44% +$3.23M ﹤0.01% 1960
2023
Q4
$6.9M Buy
2,873,984
+1,312,934
+84% +$3.15M ﹤0.01% 2176
2023
Q3
$5.31M Buy
1,561,050
+482,632
+45% +$1.64M ﹤0.01% 2225
2023
Q2
$7.93M Buy
1,078,418
+257,198
+31% +$1.89M ﹤0.01% 2015
2023
Q1
$8.51M Buy
821,220
+128,384
+19% +$1.33M ﹤0.01% 1947
2022
Q4
$8.18M Buy
692,836
+129,035
+23% +$1.52M ﹤0.01% 1973
2022
Q3
$11.8M Buy
563,801
+58,155
+12% +$1.22M ﹤0.01% 1730
2022
Q2
$15.7M Buy
505,646
+17,868
+4% +$555K 0.01% 1568
2022
Q1
$20M Buy
487,778
+18,113
+4% +$744K 0.01% 1552
2021
Q4
$20.4M Buy
469,665
+16,006
+4% +$696K 0.01% 1558
2021
Q3
$22.7M Sell
453,659
-83,282
-16% -$4.17M 0.01% 1479
2021
Q2
$33.8M Buy
536,941
+22,711
+4% +$1.43M 0.01% 1157
2021
Q1
$47.8M Sell
514,230
-85,856
-14% -$7.98M 0.02% 862
2020
Q4
$53.8M Sell
600,086
-7,826
-1% -$701K 0.02% 735
2020
Q3
$62.8M Buy
607,912
+141,726
+30% +$14.6M 0.03% 536
2020
Q2
$36.9M Sell
466,186
-39,083
-8% -$3.09M 0.02% 762
2020
Q1
$29.2M Buy
505,269
+5,609
+1% +$325K 0.02% 758
2019
Q4
$27M Buy
499,660
+21,637
+5% +$1.17M 0.01% 1006
2019
Q3
$25M Sell
478,023
-2,618
-0.5% -$137K 0.01% 996
2019
Q2
$23.2M Sell
480,641
-6,341
-1% -$306K 0.01% 1034
2019
Q1
$24.6M Buy
486,982
+50,728
+12% +$2.56M 0.02% 979
2018
Q4
$25.9M Sell
436,254
-23,130
-5% -$1.37M 0.02% 824
2018
Q3
$30.2M Buy
459,384
+22,141
+5% +$1.46M 0.02% 864
2018
Q2
$22.1M Sell
437,243
-9,348
-2% -$472K 0.02% 1005
2018
Q1
$23.5M Sell
446,591
-27,887
-6% -$1.47M 0.02% 897
2017
Q4
$22M Sell
474,478
-143,345
-23% -$6.66M 0.02% 918
2017
Q3
$25M Sell
617,823
-85,988
-12% -$3.48M 0.02% 759
2017
Q2
$23.9M Buy
703,811
+1,352
+0.2% +$45.8K 0.02% 734
2017
Q1
$20.4M Buy
702,459
+15,478
+2% +$449K 0.02% 821
2016
Q4
$22.6M Sell
686,981
-36,728
-5% -$1.21M 0.02% 682
2016
Q3
$22.8M Sell
723,709
-15,578
-2% -$491K 0.03% 611
2016
Q2
$20.8M Buy
739,287
+211,936
+40% +$5.96M 0.03% 613
2016
Q1
$19.2M Sell
527,351
-60,305
-10% -$2.19M 0.03% 625
2015
Q4
$23.5M Buy
587,656
+30,297
+5% +$1.21M 0.03% 533
2015
Q3
$15.9M Sell
557,359
-17,687
-3% -$504K 0.02% 666
2015
Q2
$18.9M Buy
575,046
+56,859
+11% +$1.87M 0.03% 603
2015
Q1
$14.9M Buy
518,187
+58,521
+13% +$1.68M 0.02% 734
2014
Q4
$12.5M Buy
459,666
+82,326
+22% +$2.24M 0.02% 747
2014
Q3
$8.04M Buy
377,340
+25,812
+7% +$550K 0.01% 989
2014
Q2
$7.9M Buy
351,528
+28,528
+9% +$641K 0.01% 1021
2014
Q1
$8.16M Buy
323,000
+79,485
+33% +$2.01M 0.01% 950
2013
Q4
$5.6M Buy
243,515
+116,469
+92% +$2.68M 0.01% 1161
2013
Q3
$2.47M Sell
127,046
-19,906
-14% -$387K 0.01% 1720
2013
Q2
$2.18M Buy
+146,952
New +$2.18M ﹤0.01% 1706